TP53 and B-cell chronic lymphocytic leukemia: Moreover, while it is widely accepted that alterations of the TP53 gene may influence the clinical course of CLL by causing resistance to chemotherapy, their impact on clonal expansion and disease progression is still not fully defined, especially in the earliest stages of the disease.